Skip to content
  • IFPMA Twitter
  • IFPMA LinkedIn
  • IFPMA Youtube
  • IFPMA Slideshare
  • IFPMA Flickr
  • IFPMA RSS
IFPMA
  • Who We Are
    • IFPMA in Brief
    • Our Governance and Leadership
    • Our Membership
      • Full Members
        • Associations
        • Companies
      • Affiliate Members
    • Our Experts
    • Join Us
  • Topics
  • News Center
    • News Releases
    • Blog
      • Global Health Matters
      • Science Matters
      • Contributors
    • Statements
    • Latest News from Our Members
  • Resources
    • Publications
      • News Releases
      • Statements
      • Position Papers
      • Publications
      • External Studies
      • Infographics
      • Event Highlights
    • Multimedia
      • Interviews
      • Podcasts
      • Videos
      • Photos
      • Slides
    • IFPMA Interactive Platforms
      • IFPMA COVID-19 Hub
      • Global Health Progress
      • 50 Years of Global Health Progress
  • Events
    • Upcoming IFPMA Events
      • Geneva Pharma Forums
      • Assemblies
      • Other IFPMA Events
      • IFPMA in External Events
      • IFPMA Press Briefings
    • Past IFPMA Events
      • Geneva Pharma Forums
      • Assemblies
      • Other IFPMA Events
      • IFPMA in External Events
      • IFPMA Press Briefings
  • Partners
  • BCR
  • Discovering medicines and Vaccines
  • Strengthening Regulatory Systems
  • Ethics and Business Integrity
  • Boosting Innovation and Access
  • Tackling Global health challenges
Economic footprint IP Pharma by numbers Sustainable innovation Value of innovation

spotlight

Value of innovation

Discovering medicines and Vaccines
African Medicines Agency Biosimilars Biotherapeutic medicines Falsified medicines Import testing Pharma by numbers Pharmacovigiliance Quality, safety, and efficacy Regulatory conferences Regulatory system strengthening / Harmonization Supply chain The Africa Regulatory Network (ARN) The ARN: Le réseau africain de réglementation pharmaceutique

spotlight

Pharmacovigiliance

Strengthening Regulatory Systems
IFPMA Code of Practice (2019) Our Ethos Code eLearning Tool IFPMA Notes for Guidance IFPMA Complaint Operating Procedure How to File a Code Complaint Complaint Submission Form Cases Business Ethics for APEC SMEs Initiative Consensus Framework for Ethical Collaboration

spotlight

IFPMA Code of Practice (2019)

Ethics and Business Integrity
Access to medicines Health technology assessment IP Pharma by numbers Trade

spotlight

Access to medicines

Boosting Innovation and Access
Ageing Antimicrobial resistance Cancer Child and maternal health Diabetes Do you mind? campaign Ebola Falsified medicines Health partnerships HIV/AIDS Humanitarian and disaster relief aid Influenza vaccine Malaria Mental and neurological disorders Neglected tropical diseases Non-communicable diseases Novel Coronavirus (COVID-19) Pandemic influenza preparedness Pharma by numbers Psoriasis Rare diseases Seasonal influenza Supply chain Sustainable development goals Tuberculosis Universal Health Coverage Vaccines innovation Vaccines protect communities Vaccines sustainability Value of immunization Viral hepatitis Workplace wellness Zika Virus

spotlight

Universal Health Coverage

Tackling Global health challenges

  • Home
  • >
  • Resources
  • >
  • Infographics
  • >
  • The R&D-based biopharmaceutical industry at the forefront of addressing AMR

The R&D-based biopharmaceutical industry at the forefront of addressing AMR

Published on: 15 September 2016

amr

Downloads

» Flyer

Resources

Declaration by the Pharmaceutical, Biotechnology and Diagnostics Industries on Combating Antimicrobial Resistance
Publications

Publications


Declaration by the Pharmaceutical, Biotechnology and Diagnostics Industries on Combating Antimicrobial Resistance

ABPI, EFPIA, and IFPMA issue joint statement on AMR
Statements

Statements


ABPI, EFPIA, and IFPMA issue joint statement on AMR

IFPMA supports WHO world health day: new efforts needed to combat AMR
News Releases

News Releases


IFPMA supports WHO world health day: new efforts needed to combat AMR

New research-based pharmaceutical industry report provides insights on how to slow down antimicrobial resistance (AMR) and boost antibiotic R&D
News Releases

News Releases


New research-based pharmaceutical industry report provides insights on how to slow down antimicrobial resistance (AMR) and boost antibiotic R&D


Related Links

Tackling Global Health Challenges-Antimicrobial Resistance
The Role of Partnerships in Supporting Innovation to Combat Antimicrobial Resistance (AMR)

Related Topics

Antimicrobial resistance

Tags

  • AMR
  • Antibiotics
  • Diagnostics
  • drug resistance
  • Industry declaration
  • Public Health
  • R&D
  • Vaccines
IFPMA

Chemin des Mines 9
1202 Geneva
Switzerland

+41 22 338 32 00
info@ifpma.org

  • File a Code Complaint
  • Privacy Policy
  • Terms of Use
  • Access to Our Extranet
  • Careers
  • Contact Us
  • IFPMA Twitter
  • IFPMA LinkedIn
  • IFPMA Youtube
  • IFPMA Slideshare
  • IFPMA Flickr
  • IFPMA RSS
Designed and Produced by ACW
^ Back to Top
Cookie Policy
This website uses cookies to ensure you get the best experience on our website. Learn More
Decline Allow Cookies